RBM15-dependent m6A modification mediates progression of non-small cell lung cancer cells

RBM15-mediated m6A methylation enhances KLF1 expression and suppresses TRIM13 via YTHDF1/YTHDF2, thereby promoting ANXA8 and facilitating NSCLC progression. These findings provide novel insights and potential therapeutic targets for NSCLC treatment.

Authors

Institutions

Publication Details

Journal
Molecular Medicine
Published
2024-12-23
DOI
https://doi.org/10.1186/s10020-024-01018-z
Citations
6
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RBM15-dependent m6A modification mediates progression of non-small cell lung cancer cells

Xiaoqi Ai, Man Wang, Ya‐Zhen Qin, Xiuhua Liu
6 citations
Molecular Medicine
RNA modifications and cancer
1.40
article

RBM15-dependent m6A modification mediates progression of non-small cell lung cancer cells

Xiaoqi Ai, Man Wang, Ya‐Zhen Qin, Xiuhua Liu
article en
6 citations

Abstract

RBM15-mediated m6A methylation enhances KLF1 expression and suppresses TRIM13 via YTHDF1/YTHDF2, thereby promoting ANXA8 and facilitating NSCLC progression. These findings provide novel insights and potential therapeutic targets for NSCLC treatment.

Molecular MedicineVol. 30(1)
Jilin University (CN), First Hospital of Jilin University (CN)
Good health and well-being
Openalex Percentile: Top 18%
RNA modifications and cancer
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.